Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Tiberi

Showing results (31-40 of 147) with videos related to

Pageof 15
Sort By:
The European Respiratory Journal|November 9, 2019
Should we worry about bedaquiline exposure in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis?Jan-Willem C Alffenaar, Onno W Akkerman, Simon Tiberi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 13, 2021
Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemicSimon Tiberi, Michael J Vjecha, Adam Zumla, et al.
The European Respiratory Journal|August 31, 2013
Bedaquiline in MDR/XDR-TB cases: first experience on compassionate useSimon Tiberi, Saverio De Lorenzo, Rosella Centis, et al.
The European Respiratory Journal|November 7, 2015
Tuberculosis elimination, patients' lives and rational use of new drugs: revisitedSimon Tiberi, Lia D'Ambrosio, Saverio De Lorenzo, et al.
The Breast Journal|September 6, 2019
Breast tuberculosis in East London: A 13-year retrospective observational studyEmma McGuire, Laura Carey, Simon Tiberi, et al.
Plos One|October 12, 2022
Using ISARIC 4C mortality score to predict dynamic changes in mortality risk in COVID-19 patients during hospital admissionTim Crocker-Buque, Jonathan Myles, Adam Brentnall, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 31, 2020
Precision and personalized medicine and anti-TB treatment: Is TDM feasible for programmatic use?Jan-Willem C Alffenaar, Onno W Akkerman, Hannah Yejin Kim, et al.
The New Microbiologica|February 5, 2010
Offer of rapid testing and alternative biological samples as practical tools to implement HIV screening programsMaria Rita Parisi, Laura Soldini, Giovanni Di Perri, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 7, 2016
Applicability of the shorter 'Bangladesh regimen' in high multidrug-resistant tuberculosis settingsGiovanni Sotgiu, Simon Tiberi, Rosella Centis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 30, 2016
Therapeutic Drug Monitoring in Tuberculosis: Practical Application for PhysiciansJan-Willem C Alffenaar, Simon Tiberi, Roger K Verbeeck, et al.
Pageof 15

Showing results (31-40 of 147) with videos related to

Sort By:
Pageof 15
The European Respiratory Journal|November 9, 2019
Should we worry about bedaquiline exposure in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis?Jan-Willem C Alffenaar, Onno W Akkerman, Simon Tiberi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 13, 2021
Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemicSimon Tiberi, Michael J Vjecha, Adam Zumla, et al.
The European Respiratory Journal|August 31, 2013
Bedaquiline in MDR/XDR-TB cases: first experience on compassionate useSimon Tiberi, Saverio De Lorenzo, Rosella Centis, et al.
The European Respiratory Journal|November 7, 2015
Tuberculosis elimination, patients' lives and rational use of new drugs: revisitedSimon Tiberi, Lia D'Ambrosio, Saverio De Lorenzo, et al.
The Breast Journal|September 6, 2019
Breast tuberculosis in East London: A 13-year retrospective observational studyEmma McGuire, Laura Carey, Simon Tiberi, et al.
Plos One|October 12, 2022
Using ISARIC 4C mortality score to predict dynamic changes in mortality risk in COVID-19 patients during hospital admissionTim Crocker-Buque, Jonathan Myles, Adam Brentnall, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 31, 2020
Precision and personalized medicine and anti-TB treatment: Is TDM feasible for programmatic use?Jan-Willem C Alffenaar, Onno W Akkerman, Hannah Yejin Kim, et al.
The New Microbiologica|February 5, 2010
Offer of rapid testing and alternative biological samples as practical tools to implement HIV screening programsMaria Rita Parisi, Laura Soldini, Giovanni Di Perri, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 7, 2016
Applicability of the shorter 'Bangladesh regimen' in high multidrug-resistant tuberculosis settingsGiovanni Sotgiu, Simon Tiberi, Rosella Centis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 30, 2016
Therapeutic Drug Monitoring in Tuberculosis: Practical Application for PhysiciansJan-Willem C Alffenaar, Simon Tiberi, Roger K Verbeeck, et al.
Pageof 15